Engineered Nanoparticles Hold Promise in Delivering Precision Cancer Treatments

11 hours ago
Alex Pearon

McGill University researchers have built tiny particle carriers that can shuttle cancer drugs straight to diseased lymph nodes without touching healthy tissue,…

Rail Vision Ltd. (NASDAQ: RVSN) Subsidiary Advances Quantum AI Strategy with New Neural Decoder Breakthrough

11 hours ago

Quantum Transportation’s system represents a patented prototype machine-learning-driven decoder aimed at addressing the complex challenges of universal quantum error correction.…

Datavault AI Inc. (NASDAQ: DVLT) Expanded Digital Engagement Through Dream Bowl Meme Token, Major Event Partnership

2 days ago

Wellgistics sponsored Dream Bowl 2026 and participated in the Datavault AI shareholder distribution plan for the Dream Bowl 2026 meme…

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Expands into Proton Therapy Through Liora Technologies, Advancing the LiGHT System for Next-Generation Cancer Care

2 days ago

LIXTE has acquired Liora Technologies Europe Ltd., securing its proprietary LiGHT system for advanced proton therapy treatment Liora works at…

Canadian Defense Strategy Categorizes Quantum Computing as a High-Value Sector

2 days ago

Ottawa's latest defense industrial roadmap treats quantum computing as a strategic priority requiring government protection and accelerated development. Quantum sits…

GridAI Corp. (NASDAQ: GRDX) Committed to Optimization of Energy Management to Meet Hyperscale AI Data Center Demands

5 days ago

With a focus on energy orchestration software rather than grid hardware or power generation, GridAI addresses the immediate need to…

Pressure from Brain Tumors Triggers Self-Destruct Mechanism in Neurons, Study Finds

1 week ago

Brain tumors may damage surrounding tissue in a more insidious way than previously understood. New research from the University of Notre Dame shows that chronic…

When Cancer Care Hits a Hardware Wall, One Microcap Is Building Around It

1 week ago

In oncology, the biggest constraints are not always science. They are often the logistics, the cost of specialized infrastructure, and…

Existing Cancer Drug Shows Potential in Reactivating Immunotherapy

1 week ago

An already approved cancer drug called Carfilzomib may help restore the effectiveness of CAR-T cell therapy in advanced multiple myeloma cases. Technical…

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Focused on Dual Narratives of Scientific Progress, Social Engagement

2 weeks ago

LIXTE recently announced advances in its approach to cancer therapy through its proprietary compound LB-100 Alongside clinical development news, LIXTE is…